1. Home
  2. Research and Funding
  3. Current Funding Opportunities
  4. Reagents for Glucagon and Incretin Research (R41/R42)

Reagents for Glucagon and Incretin Research (R41/R42)

This Funding Opportunity Announcement (FOA) invites Small Business Innovation Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) in partnership with non-profit research institutions for funding to perform research leading to the development of:

A) Validated, highly sensitive, and specific assays for plasma glucagon B) Reagents for manipulation of glucagon receptor activity in the pancreatic islet and other tissues

C) Reagents to be used to improve our understanding of pancreatic alpha-cell biology particularly in response to glucagon and incretins

D) Reagents and assays for the accurate expression and quantitation of functional incretin receptors in the endocrine/exocrine cells of the pancreas and relevant extrapancreatic tissues.

Funding Opportunity Details

PA-14-204
NOT-DK-16-030; NOT-OD-15-038; NOT-OD-16-004; NOT-OD-16-006; NOT-OD-16-011; NOT-OD-14-074

Guillermo Arreaza-Rubín, M.D.

Key Dates

7/7/2014

Not Applicable

Standard dates apply, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.